226 related articles for article (PubMed ID: 27443261)
1. Stem Cell Leukemia: how a TALented actor can go awry on the hematopoietic stage.
Correia NC; Arcangeli ML; Pflumio F; Barata JT
Leukemia; 2016 Oct; 30(10):1968-1978. PubMed ID: 27443261
[TBL] [Abstract][Full Text] [Related]
2. TAL1 as a master oncogenic transcription factor in T-cell acute lymphoblastic leukemia.
Sanda T; Leong WZ
Exp Hematol; 2017 Sep; 53():7-15. PubMed ID: 28652130
[TBL] [Abstract][Full Text] [Related]
3. The basic helix-loop-helix transcription factor TAL1/SCL inhibits the expression of the p16INK4A and pTalpha genes.
Hansson A; Manetopoulos C; Jönsson JI; Axelson H
Biochem Biophys Res Commun; 2003 Dec; 312(4):1073-81. PubMed ID: 14651981
[TBL] [Abstract][Full Text] [Related]
4. Aberrant activation of the GIMAP enhancer by oncogenic transcription factors in T-cell acute lymphoblastic leukemia.
Liau WS; Tan SH; Ngoc PCT; Wang CQ; Tergaonkar V; Feng H; Gong Z; Osato M; Look AT; Sanda T
Leukemia; 2017 Aug; 31(8):1798-1807. PubMed ID: 28028313
[TBL] [Abstract][Full Text] [Related]
5. Transcription factor SCL/TAL1 mediates the phosphorylation of MEK/ERK pathway in umbilical cord blood CD34⁺ stem cells during hematopoietic differentiation.
Zhou RQ; Wu JH; Gong YP; Guo Y; Xing HY
Blood Cells Mol Dis; 2014; 53(1-2):39-46. PubMed ID: 24405580
[TBL] [Abstract][Full Text] [Related]
6. Transcriptional regulatory networks downstream of TAL1/SCL in T-cell acute lymphoblastic leukemia.
Palomero T; Odom DT; O'Neil J; Ferrando AA; Margolin A; Neuberg DS; Winter SS; Larson RS; Li W; Liu XS; Young RA; Look AT
Blood; 2006 Aug; 108(3):986-92. PubMed ID: 16621969
[TBL] [Abstract][Full Text] [Related]
7. Aberrant TAL1 activation is mediated by an interchromosomal interaction in human T-cell acute lymphoblastic leukemia.
Patel B; Kang Y; Cui K; Litt M; Riberio MS; Deng C; Salz T; Casada S; Fu X; Qiu Y; Zhao K; Huang S
Leukemia; 2014 Feb; 28(2):349-61. PubMed ID: 23698277
[TBL] [Abstract][Full Text] [Related]
8. The SCL/TAL1 gene: roles in normal and malignant haematopoiesis.
Robb L; Begley CG
Bioessays; 1997 Jul; 19(7):607-13. PubMed ID: 9230693
[TBL] [Abstract][Full Text] [Related]
9. Differential genomic targeting of the transcription factor TAL1 in alternate haematopoietic lineages.
Palii CG; Perez-Iratxeta C; Yao Z; Cao Y; Dai F; Davison J; Atkins H; Allan D; Dilworth FJ; Gentleman R; Tapscott SJ; Brand M
EMBO J; 2011 Feb; 30(3):494-509. PubMed ID: 21179004
[TBL] [Abstract][Full Text] [Related]
10. Transcriptional regulation by TAL1: a link between epigenetic modifications and erythropoiesis.
Hu X; Ybarra R; Qiu Y; Bungert J; Huang S
Epigenetics; 2009 Aug; 4(6):357-61. PubMed ID: 19736520
[TBL] [Abstract][Full Text] [Related]
11. Impairment of granulo-monocytic development of human common myeloid progenitors but not of granulo-monocytic progenitors by decreasing stem cell leukemia/T-cell acute leukemia 1 expression.
Brunet de la Grange P; Zink E; Armstrong F; Rouyez MC; Pflumio F
Stem Cells; 2008 Jun; 26(6):1658-62. PubMed ID: 18436863
[TBL] [Abstract][Full Text] [Related]
12. SCL/TAL1 in Hematopoiesis and Cellular Reprogramming.
Hoang T; Lambert JA; Martin R
Curr Top Dev Biol; 2016; 118():163-204. PubMed ID: 27137657
[TBL] [Abstract][Full Text] [Related]
13. SCL/TAL1: a multifaceted regulator from blood development to disease.
Porcher C; Chagraoui H; Kristiansen MS
Blood; 2017 Apr; 129(15):2051-2060. PubMed ID: 28179281
[TBL] [Abstract][Full Text] [Related]
14. The transcriptional program controlled by the stem cell leukemia gene Scl/Tal1 during early embryonic hematopoietic development.
Wilson NK; Miranda-Saavedra D; Kinston S; Bonadies N; Foster SD; Calero-Nieto F; Dawson MA; Donaldson IJ; Dumon S; Frampton J; Janky R; Sun XH; Teichmann SA; Bannister AJ; Göttgens B
Blood; 2009 May; 113(22):5456-65. PubMed ID: 19346495
[TBL] [Abstract][Full Text] [Related]
15. Dynamic interaction between TAL1 oncoprotein and LSD1 regulates TAL1 function in hematopoiesis and leukemogenesis.
Li Y; Deng C; Hu X; Patel B; Fu X; Qiu Y; Brand M; Zhao K; Huang S
Oncogene; 2012 Nov; 31(48):5007-18. PubMed ID: 22310283
[TBL] [Abstract][Full Text] [Related]
16. The SCL/TAL1 Transcription Factor Represses the Stress Protein DDiT4/REDD1 in Human Hematopoietic Stem/Progenitor Cells.
Benyoucef A; Calvo J; Renou L; Arcangeli ML; van den Heuvel A; Amsellem S; Mehrpour M; Larghero J; Soler E; Naguibneva I; Pflumio F
Stem Cells; 2015 Jul; 33(7):2268-79. PubMed ID: 25858676
[TBL] [Abstract][Full Text] [Related]
17. Cross talk among Notch3, pre-TCR, and Tal1 in T-cell development and leukemogenesis.
Talora C; Cialfi S; Oliviero C; Palermo R; Pascucci M; Frati L; Vacca A; Gulino A; Screpanti I
Blood; 2006 Apr; 107(8):3313-20. PubMed ID: 16368887
[TBL] [Abstract][Full Text] [Related]
18. Ubiquitination and degradation of Tal1/SCL are induced by notch signaling and depend on Skp2 and CHIP.
Nie L; Wu H; Sun XH
J Biol Chem; 2008 Jan; 283(2):684-92. PubMed ID: 17962192
[TBL] [Abstract][Full Text] [Related]
19. FOXP3 can modulate TAL1 transcriptional activity through interaction with LMO2.
Fleskens V; Mokry M; van der Leun AM; Huppelschoten S; Pals CE; Peeters J; Coenen S; Cardoso BA; Barata JT; van Loosdregt J; Coffer PJ
Oncogene; 2016 Aug; 35(31):4141-8. PubMed ID: 26686090
[TBL] [Abstract][Full Text] [Related]
20. [Demonstration of leukemic stem cells in the human T-ALLs and study of the involvement of the NOTCH, TAL1 and ERK/MAPK pathways in human T-leukemogenesis].
Gerby B; Armstrong F; Brunet de la Grange P; Calvo J; Ballerini P; Pflumio F
Ann Pathol; 2008 Nov; 28 Spec No 1(1):S28-9. PubMed ID: 18984291
[No Abstract] [Full Text] [Related]
[Next] [New Search]
